BlackRock Mid-Cap Growth Equity Portfolio Class R (BMRRX)
Fund Assets | 11.64B |
Expense Ratio | 1.30% |
Min. Investment | $100 |
Turnover | 46.00% |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | n/a |
Previous Close | 33.54 |
YTD Return | 5.64% |
1-Year Return | 24.60% |
5-Year Return | 48.97% |
52-Week Low | 25.67 |
52-Week High | 34.44 |
Beta (5Y) | 1.28 |
Holdings | 70 |
Inception Date | Oct 2, 2006 |
About BMRRX
The fund normally invests at least 80% of its net assets in equity securities issued by U.S. mid-capitalization companies which the fund management believes have above-average earnings growth potential. The fund adviser generally defines these companies, at the time of the fund's investment, as those with market capitalizations comparable in size to the companies in the Russell Midcap® Growth Index. It primarily invests in common stock but also can invest in preferred stock, convertible securities and other equity securities.
Performance
BMRRX had a total return of 24.60% in the past year. Since the fund's inception, the average annual return has been 7.16%, including dividends.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
Symbol | Share Class | Expense Ratio |
---|---|---|
BMGCX | Investor C | 1.80% |
CMGIX | Institutional | 0.80% |
CMGSX | Service | 1.05% |
BMGAX | Investor A | 1.05% |
Top 10 Holdings
28.90% of assetsName | Symbol | Weight |
---|---|---|
Copart, Inc. | CPRT | 3.92% |
CoStar Group, Inc. | CSGP | 3.35% |
Monolithic Power Systems, Inc. | MPWR | 2.95% |
MSCI Inc. | MSCI | 2.79% |
Ares Management Corporation | ARES | 2.76% |
IDEXX Laboratories, Inc. | IDXX | 2.66% |
Axon Enterprise, Inc. | AXON | 2.66% |
West Pharmaceutical Services, Inc. | WST | 2.65% |
Entegris, Inc. | ENTG | 2.57% |
HubSpot, Inc. | HUBS | 2.57% |